NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

個人化醫療 (PM)的市場趨勢、市場佔有率、市場規模的預測 (2021-2028年):各產品 (PM診療、個體化營養&健康、DTC診斷、遠程醫療、補充醫療)、地區

Personalized Medicine Market Size, Share & Trends Analysis Report By Product (Personalized Medical Care, Personalized Nutrition & Wellness, DTC Diagnostics, Telemedicine, Complementary Medicine), And Segment Forecasts, 2021 - 2028

出版商 Grand View Research, Inc. 商品編碼 1007482
出版日期 內容資訊 英文 221 Pages
商品交期: 2-10個工作天內
價格
個人化醫療 (PM)的市場趨勢、市場佔有率、市場規模的預測 (2021-2028年):各產品 (PM診療、個體化營養&健康、DTC診斷、遠程醫療、補充醫療)、地區 Personalized Medicine Market Size, Share & Trends Analysis Report By Product (Personalized Medical Care, Personalized Nutrition & Wellness, DTC Diagnostics, Telemedicine, Complementary Medicine), And Segment Forecasts, 2021 - 2028
出版日期: 2021年05月11日內容資訊: 英文 221 Pages
簡介

全球個人化醫療 (PM)的市場規模在預測期間內預計以6.2%的年複合成長率發展,成長到2028 年7968億美元的規模。

先進性的基因分析設備的引進,搭配診斷藥的銷售,癌症與其他遺傳性疾病的發病率增加,快速門診增加等要素促進該市場的成長。

本報告提供全球個人化醫療 (PM)的市場調查,市場定義和概要,新型冠狀病毒感染疾病 (COVID-19)以及其他的市場影響因素分析,法律制度,技術趨勢,產品平台分析,市場規模的變化、預測,產品、地區/主要國家等各種區分的明細,競爭環境,主要企業簡介等彙整資訊。

第1章 摘要整理

第2章 調查手法

第3章 市場可變因素、趨勢、展望

  • 市場預測
  • 普及、成長預測製圖
  • 成本結構分析
  • 用戶的展望
  • 技術概要
  • 法律規範
  • 產品平台
  • 市場動態
  • 大環境分析、SWOT分析
  • 波特分析
  • 打入市場策略
  • 成長預測:各用途
  • COVID-19的影響

第4章 競爭分析

  • 主要企業、近幾年的發展、影響分析
  • 企業、競爭上的分類
  • 業者情勢
  • 主要企業的市場佔有率分析、排行榜
  • 公開企業
  • 非公開企業

第5章 市場預測、趨勢分析: 各產品

  • PM診斷
    • 遺傳基因檢驗
    • DTC (Direct-to-consumer) 診斷
    • Esoteric lab服務
    • Esoteric lab檢驗
  • PM治療
    • 醫藥品
    • 基因醫療
    • 醫療設備
  • PM診療
    • 遠程醫療
    • 健康資訊技術
  • 個體化營養、健康
    • 零售營養
    • 補充、替代療法

第6章 市場預測、趨勢分析:各地區、主要國家

  • 市場佔有率成果、預測
  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東、非洲

第7章 競爭情形

  • 策略性架構
  • 進入經營者的分類
  • 企業簡介
    • GE Healthcare
    • Illumina, Inc.
    • ASURAGEN, INC.
    • Danaher
    • Abbott Laboratories
    • Exact Sciences Corporation
    • Biogen International
    • Exagen Inc.
    • Genelex Corporation
    • Precision Biologics, Inc.
    • QIAGEN
    • IBM
    • Genentech, Inc.
    • 23andME, Inc.
目錄
Product Code: 978-1-68038-443-7

Personalized Medicine Market Growth & Trends

The global personalized medicine market size is expected to reach USD 796.8 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 6.2% from 2021 to 2028. The market growth can be attributed to several factors such as the high adoption of advanced genome sequencing instruments, the launch of companion diagnostics, and the rising incidence of cancer and other genetic disorders.

In addition, the growing number of retail clinics is further boosting market growth. There is a high adoption rate of telemedicine solutions observed in retail clinics. With the integration of these solutions, retails clinics provide online scheduling solutions to patients along with contactless check-in and payment modes. Hence, such advanced solutions based on telemedicine are contributing to the growth of the market.

Moreover, the robust funding for supporting research on PM and cell therapy is contributing to the market growth. For instance, in May 2020, the Minderoo Foundation and the Federal government granted around USD 67.0 million for the Zero Childhood Cancer program (ZERO). The funding facilitated the development of a comprehensive genomic databank of individual patient's cancer and healthy cells, facilitating in better understanding of childhood cancer.

Expanding presence of established players in distinct sectors of PM is also set to propel market growth. These are inclusive of companies such as Google and IBM among others. In November 2020, DeepMind, a Google company, announced that made a huge leap in the 3D analysis of proteins from their amino-acid sequence. This is expected to be a revolutionary development in the field of PM diagnostics.

Furthermore, PM is bringing a new paradigm in the ongoing COVID-19 pandemic. With the application of PM, researchers can identify the best management strategies for accurate diagnosis. This in turn will facilitate in designing the therapeutic approaches based on individual COVID-19 patients. However, these medicines are better suited for inherited diseases and conditions such as cancer that are developed owing to genetic mutations rather than infectious diseases.

Personalized Medicine Market Report Highlights

The personalized nutrition and wellness segment accounted for the largest revenue share in 2020 owing to the growing demand for products of this segment and less regulatory compliance

The expanding pool of operational entities in this segment is expected to boost the sales of personalized nutrition products

The therapeutics segment is expected to witness lucrative growth over the forecast period owing to the extensive usage of pharmacogenomics for developing biopharmaceuticals

In therapeutics, the genomic medicine segment is expected to witness substantial growth through the forecast period owing to a reduction in costs of whole-genome sequencing

North America held the largest revenue share in 2020. The growth of the market in this region is owing to intensive research for the development of new therapies

In Asia Pacific, the market is expected to witness the fastest CAGR over the forecast period owing to growing PM startups and favorable government initiatives

Companies operating in the market are receiving the U.S. FDA approvals for their personalized medicines. For instance, in February 2021, Biogen Inc. received the U.S. FDA approval for PLEGRIDY (peginterferon beta-1a) for treating patients with relapsing forms of Multiple Sclerosis (MS)

Table of Contents

Chapter 1 Executive Summary

  • 1.1 Personalized Medicine Market Outlook, 2017 - 2028
  • 1.2 Personalized Medicine Market: Segment Outlook, 2017 - 2028

Chapter 2 Research Methodology

  • 2.1 Information Procurement
    • 2.1.1 Purchased database:
    • 2.1.2 GVR's Internal Database
    • 2.1.3 Secondary sources:
    • 2.1.4 Third Party Perspective:
    • 2.1.5 Primary Research:
  • 2.2 Data Analysis
  • 2.3 Market Formulation & Validation
  • 2.4 Region Wise Market Calculation
    • 2.4.1 Region wise market: Base estimates
    • 2.4.2 Global market: CAGR calculation
    • 2.4.3 Region based segment share calculation

Chapter 3 Market Variables, Trends& Scope

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent market outlook
    • 3.1.2 Related/ ancillary market outlook
  • 3.2 Penetration & Growth Prospect Mapping for PM Diagnostics & PM Therapeutics, 2020
  • 3.3 Penetration & Growth Prospect Mapping for PM Medical Care & PM Nutrition & Wellness, 2020
  • 3.4 Cost Structure Analysis
  • 3.5 User Perspective Analysis
    • 3.5.1 Consumer behaviour analysis
    • 3.5.2 Market influencer analysis
  • 3.6 Technology Overview
    • 3.6.1 OMICs technology
      • 3.6.1.1 Cross-technology coordination
      • 3.6.1.2 Data management: Analytics, sharing, security, and storage
    • 3.6.2 Sequencing technology
    • 3.6.3 Polymerase Chain Reaction(PCR)
    • 3.6.4 In situ hybridization
    • 3.6.5 Immunohistochemistry
    • 3.6.6 Other technologies
  • 3.7 Regulatory Framework
    • 3.7.1 Reimbursement framework
  • 3.8 Product Pipeline Analysis
  • 3.9 Personalized Medicine Market- Market Dynamics
    • 3.9.1 Market driver analysis
      • 3.9.1.1 Advancements in next generation sequencing technology
      • 3.9.1.2 Expanding portfolio of companion/associated diagnostics
      • 3.9.1.3 Increasing number of retail clinics across the developed regions of North America and Europe
      • 3.9.1.4 Increasing prevalence of cancer & usage of biomarkers for PM cancer therapy
      • 3.9.1.5 Growing healthcare expenditure triggering development of effective PM diagnostic & therapeutic procedure for cancer
    • 3.9.2 Market restraint analysis
      • 3.9.2.1 Lack of proper intellectual property regulations for personalized medical technologies
      • 3.9.2.2 Non-structural development of biomarkers
    • 3.9.3 Market challenge analysis
      • 3.9.3.1 Burden of proof is greater for clinical validation for PM therapeutics
  • 3.10 SWOT By PESTLE Analysis
    • 3.10.1 Political landscape
    • 3.10.2 Economic landscape
    • 3.10.3 Social landscape
    • 3.10.4 Technology landscape
  • 3.11 Industry Analysis - Porter's
    • 3.11.1 Bargaining power of suppliers: Moderate
    • 3.11.2 Bargaining power of buyers: Moderate
    • 3.11.3 Threat of substitution: Low
    • 3.11.4 Threat of new entrants: Moderate
    • 3.11.5 Competitive rivalry: High
  • 3.12 Market Entry Strategies
    • 3.12.1 Diagnostics companies:
    • 3.12.2 Pharmaceutical and biotechnology companies
    • 3.12.3 Raw material supplier
    • 3.12.4 Distributor
    • 3.12.5 Collaborations between diagnostic and pharma entities
  • 3.13 Personalized Medicine - Application Growth Prospects Analysis
    • 3.13.1 Personalized medicine - Application opportunity v/s implementation
    • 3.13.2 Personalized medicine - Application opportunities prioritized
  • 3.14 COVID-19 Impact on Personalized Medicine Market

Chapter 4 Competitive Analysis

  • 4.1 Recent Developments & Impact Analysis, by Key Market Participants
  • 4.2 Company/Competition Categorization
  • 4.3 Vendor Landscape
    • 4.3.1 List of key distributors and channel partners
    • 4.3.2 Key customers
  • 4.4 Key Company Market Share Analysis/Ranking, 2020
    • 4.4.1 Company financial size
    • 4.4.2 Product portfolio
    • 4.4.3 Geographic footprint
    • 4.4.4 Innovation
    • 4.4.5 Pipeline
    • 4.4.6 Strategic initiatives
  • 4.5 Public Companies
    • 4.5.1 Company market position analysis
      • 4.5.1.1 Number of products
      • 4.5.1.2 Market penetration
      • 4.5.1.3 Strategic initiatives
      • 4.5.1.4 Segment coverage
      • 4.5.1.5 Geographical presence
      • 4.5.1.6 Conclusion
    • 4.5.2 Competitive dashboard analysis
    • 4.5.3 Market differentiators
    • 4.5.4 Synergy analysis: Major deals & strategic alliances
  • 4.6 Private Companies
    • 4.6.1 List of key emerging companies
    • 4.6.2 Funding outlook
    • 4.6.3 Regional network map
    • 4.6.4 Company market position analysis
    • 4.6.5 List of suppliers

Chapter 5 Personalized Medicine Market Categorization: Product Estimates & Trend Analysis

  • 5.1 Market: Product Movement Analysis
  • 5.2 Personalized Medicine Diagnostics
    • 5.2.1 Market, 2017 - 2028 (USD Billion)
    • 5.2.2 Genetic testing
      • 5.2.2.1 Market, 2017 - 2028 (USD Billion)
    • 5.2.3 Direct-to-consumer (DTC) diagnostics
      • 5.2.3.1 Market, 2017 - 2028 (USD Billion)
    • 5.2.4 Esoteric lab services
      • 5.2.4.1 Market, 2017 - 2028 (USD Billion)
    • 5.2.5 Esoteric lab tests
      • 5.2.5.1 Market, 2017 - 2028 (USD Billion)
  • 5.3 PM Therapeutics
    • 5.3.1 Market, 2017 - 2028 (USD Billion)
    • 5.3.2 Pharmaceuticals
      • 5.3.2.1 Market, 2017 - 2028 (USD Billion)
    • 5.3.3 Genomic medicine
      • 5.3.3.1 Market, 2017 - 2028 (USD Billion)
    • 5.3.4 Medical devices
      • 5.3.4.1 Market, 2017 - 2028 (USD Billion)
  • 5.4 Personalized Medical Care
    • 5.4.1 Market, 2017 - 2028 (USD Billion)
    • 5.4.2 Telemedicine
      • 5.4.2.1 Global Telemedicine Market, 2017 - 2028 (USD Billion)
    • 5.4.3 Health Information Technology
      • 5.4.3.1 Market, 2017 - 2028 (USD Billion)
  • 5.5 Personalized Nutrition & Wellness
    • 5.5.1 Market, 2017 - 2028 (USD Billion)
    • 5.5.2 Retail Nutrition
      • 5.5.2.1 Market, 2017 - 2028 (USD Billion)
    • 5.5.3 Complementary & Alternative Medicine
      • 5.5.3.1 Market, 2017 - 2028 (USD Billion)

Chapter 6 Personalized Medicine Market Categorization: Regional Estimates & Trend Analysis, by Product

  • 6.1 Market Share by Region, 2018 & 2025
  • 6.2 North America
    • 6.2.1 Market, 2017 - 2028 (USD Billion)
    • 6.2.2 U.S.
      • 6.2.2.1 Market, by product, 2017 - 2028 (USD Billion)
      • 6.2.2.2 Market, by personalized medicine diagnostics, 2017 - 2028 (USD Billion)
      • 6.2.2.3 Market, by personalized medicine therapeutics, 2017 - 2028 (USD Billion)
      • 6.2.2.4 Market, by personalized medical care, 2017 - 2028 (USD Billion)
      • 6.2.2.5 Market, by personalized nutrition & wellness, 2017 - 2028 (USD Billion)
    • 6.2.3 Canada
      • 6.2.3.1 Market, by product, 2017 - 2028 (USD Billion)
      • 6.2.3.2 Market, by personalized medicine diagnostics, 2017 - 2028 (USD Billion)
      • 6.2.3.3 Market, by personalized medicine therapeutics, 2017 - 2028 (USD Billion)
      • 6.2.3.4 Market, by personalized medical care, 2017 - 2028 (USD Billion)
      • 6.2.3.5 Market, by personalized nutrition & wellness, 2017 - 2028 (USD Billion)
  • 6.3 Europe
    • 6.3.1 Market, 2017 - 2028 (USD Billion)
    • 6.3.2 Germany
      • 6.3.2.1 Market, by product, 2017 - 2028 (USD Billion)
      • 6.3.2.2 Market, by personalized medicine diagnostics, 2017 - 2028 (USD Billion)
      • 6.3.2.3 Market, by personalized medicine therapeutics, 2017 - 2028 (USD Billion)
      • 6.3.2.4 Market, by personalized medical care, 2017 - 2028 (USD Billion)
      • 6.3.2.5 Market, by personalized nutrition & wellness, 2017 - 2028 (USD Billion)
    • 6.3.3 U.K.
      • 6.3.3.1 Market, by product, 2017 - 2028 (USD Billion)
      • 6.3.3.2 Market, by personalized medicine diagnostics, 2017 - 2028 (USD Billion)
      • 6.3.3.3 Market, by personalized medicine therapeutics, 2017 - 2028 (USD Billion)
      • 6.3.3.4 Market, by personalized medical care, 2017 - 2028 (USD Billion)
      • 6.3.3.5 Market, by personalized nutrition & wellness, 2017 - 2028 (USD Billion)
    • 6.3.4 Italy
      • 6.3.4.1 Market, by product, 2017 - 2028 (USD Billion)
      • 6.3.4.2 Market, by personalized medicine diagnostics, 2017 - 2028 (USD Billion)
      • 6.3.4.3 Market, by personalized medicine therapeutics, 2017 - 2028 (USD Billion)
      • 6.3.4.4 Market, by personalized medical care, 2017 - 2028 (USD Billion)
      • 6.3.4.5 Market, by personalized nutrition & wellness, 2017 - 2028 (USD Billion)
    • 6.3.5 France
      • 6.3.5.1 Market, by product, 2017 - 2028 (USD Billion)
      • 6.3.5.2 Market, by personalized medicine diagnostics, 2017 - 2028 (USD Billion)
      • 6.3.5.3 Market, by personalized medicine therapeutics, 2017 - 2028 (USD Billion)
      • 6.3.5.4 Market, by personalized medical care, 2017 - 2028 (USD Billion)
      • 6.3.5.5 Market, by personalized nutrition & wellness, 2017 - 2028 (USD Billion)
  • 6.4 Asia Pacific
    • 6.4.1 Market, 2017 - 2028 (USD Billion)
    • 6.4.2 Japan
      • 6.4.2.1 Market, by product, 2017 - 2028 (USD Billion)
      • 6.4.2.2 Market, by personalized medicine diagnostics, 2017 - 2028 (USD Billion)
      • 6.4.2.3 Market, by personalized medicine therapeutics, 2017 - 2028 (USD Billion)
      • 6.4.2.4 Market, by personalized medical care, 2017 - 2028 (USD Billion)
      • 6.4.2.5 Market, by personalized nutrition & wellness, 2017 - 2028 (USD Billion)
    • 6.4.3 China
      • 6.4.3.1 Market, by product, 2017 - 2028 (USD Billion)
      • 6.4.3.2 Market, by personalized medicine diagnostics, 2017 - 2028 (USD Billion)
      • 6.4.3.3 Market, by personalized medicine therapeutics, 2017 - 2028 (USD Billion)
      • 6.4.3.4 Market, by personalized medical care, 2017 - 2028 (USD Billion)
      • 6.4.3.5 Market, by personalized nutrition & wellness, 2017 - 2028 (USD Billion)
    • 6.4.4 India
      • 6.4.4.1 Market, by product, 2017 - 2028 (USD Billion)
      • 6.4.4.2 Market, by personalized medicine diagnostics, 2017 - 2028 (USD Billion)
      • 6.4.4.3 Market, by personalized medicine therapeutics, 2017 - 2028 (USD Billion)
      • 6.4.4.4 Market, by personalized medical care, 2017 - 2028 (USD Billion)
      • 6.4.4.5 Market, by personalized nutrition & wellness, 2017 - 2028 (USD Billion)
    • 6.4.5 South Korea
      • 6.4.5.1 Market, by product, 2017 - 2028 (USD Billion)
      • 6.4.5.2 Market, by personalized medicine diagnostics, 2017 - 2028 (USD Billion)
      • 6.4.5.3 Market, by personalized medicine therapeutics, 2017 - 2028 (USD Billion)
      • 6.4.5.4 Market, by personalized medical care, 2017 - 2028 (USD Billion)
      • 6.4.5.5 Market, by personalized nutrition & wellness, 2017 - 2028 (USD Billion)
  • 6.5 Latin America
    • 6.5.1 Market, 2017 - 2028 (USD Billion)
    • 6.5.2 Brazil
      • 6.5.2.1 Market, by product, 2017 - 2028 (USD Billion)
      • 6.5.2.2 Market, by personalized medicine diagnostics, 2017 - 2028 (USD Billion)
      • 6.5.2.3 Market, by personalized medicine therapeutics, 2017 - 2028 (USD Billion)
      • 6.5.2.4 Market, by personalized medical care, 2017 - 2028 (USD Billion)
      • 6.5.2.5 Market, by personalized nutrition & wellness, 2017 - 2028 (USD Billion)
    • 6.5.3 Mexico
      • 6.5.3.1 Market, by product, 2017 - 2028 (USD Billion)
      • 6.5.3.2 Market, by personalized medicine diagnostics, 2017 - 2028 (USD Billion)
      • 6.5.3.3 Market, by personalized medicine therapeutics, 2017 - 2028 (USD Billion)
      • 6.5.3.4 Market, by personalized medical care, 2017 - 2028 (USD Billion)
      • 6.5.3.5 Market, by personalized nutrition & wellness, 2017 - 2028 (USD Billion)
  • 6.6 Middle East & Africa
    • 6.6.1 Market, 2017 - 2028 (USD Billion)
    • 6.6.2 South Africa
      • 6.6.2.1 Market, by product, 2017 - 2028 (USD Billion)
      • 6.6.2.2 Market, by personalized medicine diagnostics, 2017 - 2028 (USD Billion)
      • 6.6.2.3 Market, by personalized medicine therapeutics, 2017 - 2028 (USD Billion)
      • 6.6.2.4 Market, by personalized medical care, 2017 - 2028 (USD Billion)
      • 6.6.2.5 Market, by personalized nutrition & wellness, 2017 - 2028 (USD Billion)
    • 6.6.3 Saudi Arabia
      • 6.6.3.1 Market, by product, 2017 - 2028 (USD Billion)
      • 6.6.3.2 Market, by personalized medicine diagnostics, 2017 - 2028 (USD Billion)
      • 6.6.3.3 Market, by personalized medicine therapeutics, 2017 - 2028 (USD Billion)
      • 6.6.3.4 Market, by personalized medical care, 2017 - 2028 (USD Billion)
      • 6.6.3.5 Market, by personalized nutrition & wellness, 2017 - 2028 (USD Billion)

Chapter 7 Competitive Landscape

  • 7.1 Strategy Framework
  • 7.2 Market Participation Categorization
  • 7.3 Company Profiles
    • 7.3.1 GE Healthcare
      • 7.3.1.1 Company overview
      • 7.3.1.2 Financial performance
      • 7.3.1.3 Product Benchmarking
      • 7.3.1.4 Strategic initiatives
    • 7.3.2 Illumina, Inc.
      • 7.3.2.1 Company overview
      • 7.3.2.2 Financial performance
      • 7.3.2.3 Product benchmarking
      • 7.3.2.4 Strategic initiatives
    • 7.3.3 ASURAGEN, INC.
      • 7.3.3.1 Company overview
      • 7.3.3.2 Product benchmarking
      • 7.3.3.3 Strategic initiatives
    • 7.3.4 Danaher
      • 7.3.4.1 Company overview
      • 7.3.4.2 Cepheid
      • 7.3.4.2.1 Company overview
      • 7.3.4.3 Financial performance
      • 7.3.4.4 Product benchmarking
      • 7.3.4.5 Strategic initiatives
    • 7.3.5 Abbott Laboratories
      • 7.3.5.1 Company overview
      • 7.3.5.2 Financial performance
      • 7.3.5.3 Product benchmarking
      • 7.3.5.4 Strategic Initiatives
    • 7.3.6 Exact Sciences Corporation
      • 7.3.6.1 Company overview
      • 7.3.6.2 Financial performance
      • 7.3.6.3 Product benchmarking
      • 7.3.6.4 Strategic initiatives
    • 7.3.7 Biogen International
      • 7.3.7.1 Company overview
      • 7.3.7.2 Financial performance
      • 7.3.7.3 Product benchmarking
      • 7.3.7.4 Strategic initiatives
    • 7.3.8 Exagen Inc.
      • 7.3.8.1 Company overview
      • 7.3.8.2 Product benchmarking
      • 7.3.8.3 Strategic initiatives
    • 7.3.9 Genelex Corporation
      • 7.3.9.1 Company overview
      • 7.3.9.2 Product benchmarking
      • 7.3.9.3 Strategic initiatives
    • 7.3.10 Precision Biologics, Inc.
      • 7.3.10.1 Company overview
      • 7.3.10.2 Product benchmarking
      • 7.3.10.3 Strategic initiatives
    • 7.3.11 QIAGEN
      • 7.3.11.1 Company overview
      • 7.3.11.2 Financial performance
      • 7.3.11.3 Product benchmarking
      • 7.3.11.4 Strategic initiatives
    • 7.3.12 IBM
      • 7.3.12.1 Company overview
      • 7.3.12.2 Financial performance
      • 7.3.12.3 Product benchmarking
      • 7.3.12.4 Strategic initiatives
    • 7.3.13 Genentech, Inc.
      • 7.3.13.1 Company overview
      • 7.3.13.2 Financial performance
      • 7.3.13.3 Product benchmarking
      • 7.3.13.4 Strategic initiatives
    • 7.3.14 23andME, Inc.
      • 7.3.14.1 Company overview
      • 7.3.14.2 Financial performance
      • 7.3.14.3 Product benchmarking
      • 7.3.14.4 Strategic initiatives

List of Tables

  • TABLE 1 Country share estimation
  • TABLE 2 FDA-approved and CE-marked tests with an epigenetic component
  • TABLE 3 Pipeline program of Cellworks
  • TABLE 4 List of distributors and channel partners
  • TABLE 5 List of emerging companies
  • TABLE 6 List of suppliers
  • TABLE 7 Healthcare expenditure levels, 2020
  • TABLE 8 North America personalized medicine market estimates & forecasts, by product, 2017 - 2028 (USD Billion)
  • TABLE 9 North America market estimates & forecasts, by personalized medicine diagnostics, 2017 - 2028 (USD Billion)
  • TABLE 10 North America market estimates & forecasts, by personalized medicine therapeutics, 2017 - 2028 (USD Billion)
  • TABLE 11 North America market estimates & forecasts, by personalized medical care, 2017 - 2028 (USD Billion)
  • TABLE 12 North America market estimates & forecasts, by personalized nutrition & wellness, 2017 - 2028 (USD Billion)
  • TABLE 13 U.S. personalized medicine market estimates & forecasts, by product, 2017 - 2028 (USD Billion)
  • TABLE 14 U.S. market estimates & forecasts, by personalized medicine diagnostics, 2017 - 2028 (USD Billion)
  • TABLE 15 U.S. market estimates & forecasts, by personalized medicine therapeutics, 2017 - 2028 (USD Billion)
  • TABLE 16 U.S. market estimates & forecasts, by personalized medical care, 2017 - 2028 (USD Billion)
  • TABLE 17 U.S. market estimates & forecasts, by personalized nutrition & wellness, 2017 - 2028 (USD Billion)
  • TABLE 18 Canada personalized medicine market estimates & forecasts, by product, 2017 - 2028 (USD Billion)
  • TABLE 19 Canada market estimates & forecasts, by personalized medicine diagnostics, 2017 - 2028 (USD Billion)
  • TABLE 20 Canada market estimates & forecasts, by personalized medicine therapeutics, 2017 - 2028 (USD Billion)
  • TABLE 21 Canada market estimates & forecasts, by personalized medical care, 2017 - 2028 (USD Billion)
  • TABLE 22 Canada market estimates & forecasts, by personalized nutrition & wellness, 2017 - 2028 (USD Billion)
  • TABLE 23 Europe personalized medicine market estimates & forecasts, by product, 2017 - 2028 (USD Billion)
  • TABLE 24 Europe market estimates & forecasts, by personalized medicine diagnostics, 2017 - 2028 (USD Billion)
  • TABLE 25 Europe market estimates & forecasts, by personalized medicine therapeutics, 2017 - 2028 (USD Billion)
  • TABLE 26 Europe market estimates & forecasts, by personalized medical care, 2017 - 2028 (USD Billion)
  • TABLE 27 Europe market estimates & forecasts, by personalized nutrition & wellness, 2017 - 2028 (USD Billion)
  • TABLE 28 Germany personalized medicine market estimates & forecasts, by product, 2017 - 2028 (USD Billion)
  • TABLE 29 Germany market estimates & forecasts, by personalized medicine diagnostics, 2017 - 2028 (USD Billion)
  • TABLE 30 Germany market estimates & forecasts, by personalized medicine therapeutics, 2017 - 2028 (USD Billion)
  • TABLE 31 Germany market estimates & forecasts, by personalized medical care, 2017 - 2028 (USD Billion)
  • TABLE 32 Germany market estimates & forecasts, by personalized nutrition & wellness, 2017 - 2028 (USD Billion)
  • TABLE 33 U.K. personalized medicine market estimates & forecasts, by product, 2017 - 2028 (USD Billion)
  • TABLE 34 U.K. market estimates & forecasts, by personalized medicine diagnostics, 2017 - 2028 (USD Billion)
  • TABLE 35 U.K. market estimates & forecasts, by personalized medicine therapeutics, 2017 - 2028 (USD Billion)
  • TABLE 36 U.K. market estimates & forecasts, by personalized medical care, 2017 - 2028 (USD Billion)
  • TABLE 37 U.K. market estimates & forecasts, by personalized nutrition & wellness, 2017 - 2028 (USD Billion)
  • TABLE 38 Italy personalized medicine market estimates & forecasts, by product, 2017 - 2028 (USD Billion)
  • TABLE 39 Italy market estimates & forecasts, by personalized medicine diagnostics, 2017 - 2028 (USD Billion)
  • TABLE 40 Italy market estimates & forecasts, by personalized medicine therapeutics, 2017 - 2028 (USD Billion)
  • TABLE 41 Italy market estimates & forecasts, by personalized medical care, 2017 - 2028 (USD Billion)
  • TABLE 42 Italy market estimates & forecasts, by personalized nutrition & wellness, 2017 - 2028 (USD Billion)
  • TABLE 43 France personalized medicine market estimates & forecasts, by product, 2017 - 2028 (USD Billion)
  • TABLE 44 France market estimates & forecasts, by personalized medicine diagnostics, 2017 - 2028 (USD Billion)
  • TABLE 45 France market estimates & forecasts, by personalized medicine therapeutics, 2017 - 2028 (USD Billion)
  • TABLE 46 France market estimates & forecasts, by personalized medical care, 2017 - 2028 (USD Billion)
  • TABLE 47 France market estimates & forecasts, by personalized nutrition & wellness, 2017 - 2028 (USD Billion)
  • TABLE 48 Asia Pacific personalized medicine market estimates & forecasts, by product, 2017 - 2028 (USD Billion)
  • TABLE 49 Asia Pacific market estimates & forecasts, by personalized medicine diagnostics, 2017 - 2028 (USD Billion)
  • TABLE 50 Asia Pacific market estimates & forecasts, by personalized medicine therapeutics, 2017 - 2028 (USD Billion)
  • TABLE 51 Asia Pacific market estimates & forecasts, by personalized medical care, 2017 - 2028 (USD Billion)
  • TABLE 52 Asia Pacific market estimates & forecasts, by personalized nutrition & wellness, 2017 - 2028 (USD Billion)
  • TABLE 53 Japan personalized medicine market estimates & forecasts, by product, 2017 - 2028 (USD Billion)
  • TABLE 54 Japan market estimates & forecasts, by personalized medicine diagnostics, 2017 - 2028 (USD Billion)
  • TABLE 55 Japan market estimates & forecasts, by personalized medicine therapeutics, 2017 - 2028 (USD Billion)
  • TABLE 56 Japan market estimates & forecasts, by personalized medical care, 2017 - 2028 (USD Billion)
  • TABLE 57 Japan market estimates & forecasts, by personalized nutrition & wellness, 2017 - 2028 (USD Billion)
  • TABLE 58 China personalized medicine market estimates & forecasts, by product, 2017 - 2028 (USD Billion)
  • TABLE 59 China market estimates & forecasts, by personalized medicine diagnostics, 2017 - 2028 (USD Billion)
  • TABLE 60 China market estimates & forecasts, by personalized medicine therapeutics, 2017 - 2028 (USD Billion)
  • TABLE 61 China market estimates & forecasts, by personalized medical care, 2017 - 2028 (USD Billion)
  • TABLE 62 China market estimates & forecasts, by personalized nutrition & wellness, 2017 - 2028 (USD Billion)
  • TABLE 63 India personalized medicine market estimates & forecasts, by product, 2017 - 2028 (USD Billion)
  • TABLE 64 India market estimates & forecasts, by personalized medicine diagnostics, 2017 - 2028 (USD Billion)
  • TABLE 65 India market estimates & forecasts, by personalized medicine therapeutics, 2017 - 2028 (USD Billion)
  • TABLE 66 India market estimates & forecasts, by personalized medical care, 2017 - 2028 (USD Billion)
  • TABLE 67 India market estimates & forecasts, by personalized nutrition & wellness, 2017 - 2028 (USD Billion)
  • TABLE 68 South Korea personalized medicine market estimates & forecasts, by product, 2017 - 2028 (USD Billion)
  • TABLE 69 South Korea market estimates & forecasts, by personalized medicine diagnostics, 2017 - 2028 (USD Billion)
  • TABLE 70 South Korea market estimates & forecasts, by personalized medicine therapeutics, 2017 - 2028 (USD Billion)
  • TABLE 71 South Korea market estimates & forecasts, by personalized medical care, 2017 - 2028 (USD Billion)
  • TABLE 72 South Korea market estimates & forecasts, by personalized nutrition & wellness, 2017 - 2028 (USD Billion)
  • TABLE 73 Latin America personalized medicine market estimates & forecasts, by product, 2017 - 2028 (USD Billion)
  • TABLE 74 Latin America market estimates & forecasts, by personalized medicine diagnostics, 2017 - 2028 (USD Billion)
  • TABLE 75 Latin America market estimates & forecasts, by personalized medicine therapeutics, 2017 - 2028 (USD Billion)
  • TABLE 76 Latin America market estimates & forecasts, by personalized medical care, 2017 - 2028 (USD Billion)
  • TABLE 77 Latin America market estimates & forecasts, by personalized nutrition & wellness, 2017 - 2028 (USD Billion)
  • TABLE 78 Brazil personalized medicine market estimates & forecasts, by product, 2017 - 2028 (USD Billion)
  • TABLE 79 Brazil market estimates & forecasts, by personalized medicine diagnostics, 2017 - 2028 (USD Billion)
  • TABLE 80 Brazil market estimates & forecasts, by personalized medicine therapeutics, 2017 - 2028 (USD Billion)
  • TABLE 81 Brazil market estimates & forecasts, by personalized medical care, 2017 - 2028 (USD Billion)
  • TABLE 82 Brazil market estimates & forecasts, by personalized nutrition & wellness, 2017 - 2028 (USD Billion)
  • TABLE 83 Mexico personalized medicine market estimates & forecasts, by product, 2017 - 2028 (USD Billion)
  • TABLE 84 Mexico market estimates & forecasts, by personalized medicine diagnostics, 2017 - 2028 (USD Billion)
  • TABLE 85 Mexico market estimates & forecasts, by personalized medicine therapeutics, 2017 - 2028 (USD Billion)
  • TABLE 86 Mexico market estimates & forecasts, by personalized medical care, 2017 - 2028 (USD Billion)
  • TABLE 87 Mexico market estimates & forecasts, by personalized nutrition & wellness, 2017 - 2028 (USD Billion)
  • TABLE 88 MEA personalized medicine market estimates & forecasts, by product, 2017 - 2028 (USD Billion)
  • TABLE 89 MEA market estimates & forecasts, by personalized medicine diagnostics, 2017 - 2028 (USD Billion)
  • TABLE 90 MEA market estimates & forecasts, by personalized medicine therapeutics, 2017 - 2028 (USD Billion)
  • TABLE 91 MEA market estimates & forecasts, by personalized medical care, 2017 - 2028 (USD Billion)
  • TABLE 92 MEA market estimates & forecasts, by personalized nutrition & wellness, 2017 - 2028 (USD Billion)
  • TABLE 93 South Africa personalized medicine market estimates & forecasts, by product, 2017 - 2028 (USD Billion)
  • TABLE 94 South Africa market estimates & forecasts, by personalized medicine diagnostics, 2017 - 2028 (USD Billion)
  • TABLE 95 South Africa market estimates & forecasts, by personalized medicine therapeutics, 2017 - 2028 (USD Billion)
  • TABLE 96 South Africa market estimates & forecasts, by personalized medical care, 2017 - 2028 (USD Billion)
  • TABLE 97 South Africa market estimates & forecasts, by personalized nutrition & wellness, 2017 - 2028 (USD Billion)
  • TABLE 98 Saudi Arabia personalized medicine market estimates & forecasts, by product, 2017 - 2028 (USD Billion)
  • TABLE 99 Saudi Arabia market estimates & forecasts, by personalized medicine diagnostics, 2017 - 2028 (USD Billion)
  • TABLE 100 Saudi Arabia market estimates & forecasts, by personalized medicine therapeutics, 2017 - 2028 (USD Billion)
  • TABLE 101 Saudi Arabia market estimates & forecasts, by personalized medical care, 2017 - 2028 (USD Billion)
  • TABLE 102 Saudi Arabia market estimates & forecasts, by personalized nutrition & wellness, 2017 - 2028 (USD Billion)

List of Figures

  • FIG. 1 Market segmentation & scope
  • FIG. 2 Market summary
  • FIG. 3 Market research process
  • FIG. 4 Information procurement
  • FIG. 5 Primary research pattern
  • FIG. 6 Market research approaches
  • FIG. 7 Value chain-based sizing & forecasting
  • FIG. 8 QFD modelling for market share assessment
  • FIG. 9 Parent market outlook
  • FIG. 10 Penetration & growth prospect mapping for PM diagnostics & PM therapeutics, 2020
  • FIG. 11 Penetration & growth prospect mapping for PM medical care & PM nutrition & wellness, 2020
  • FIG. 12 Consumer awareness of personalized medicine
  • FIG. 13 PCR-based platforms for mutation detection
  • FIG. 14 Companion diagnostics pipeline, as of March 2020
  • FIG. 15 Market trends & outlook
  • FIG. 16 Market driver relevance analysis (Current & future impact)
  • FIG. 17 DNA sequencing cost per genome
  • FIG. 18 Global cancer incidence, as of September 2020
  • FIG. 19 Use of cancer biomarkers in cancer management
  • FIG. 20 Expected rise in expenditure for cancer treatment (USD Billion)
  • FIG. 21 Growth in number of personalized medicines available in the U.S. from 2008 to 2020
  • FIG. 22 Market restraint relevance analysis (Current & future impact)
  • FIG. 23 Business models for market entry
  • FIG. 24 Marketing channels
  • FIG. 25 Personalized medicine - application opportunity v/s implementation
  • FIG. 26 Personalized medicine - Application opportunities prioritized
  • FIG. 27 Impact analysis by key companies
  • FIG. 28 Company categorization
  • FIG. 29 Heat map analysis of top key players, 2020
  • FIG. 30 Public companies market position analysis
  • FIG. 31 Competitive dashboard analysis for public players
  • FIG. 32 Regional network map for private players
  • FIG. 33 Personalized medicine market: Product outlook key takeaways
  • FIG. 34 Personalized medicine market: Product movement analysis
  • FIG. 35 Global personalized medicine diagnostics market, 2017 - 2028 (USD Billion)
  • FIG. 36 Global genetic testing market, 2017 - 2028 (USD Billion)
  • FIG. 37 Global DTC diagnostics market, 2017 - 2028 (USD Billion)
  • FIG. 38 Global esoteric lab services market, 2017 - 2028 (USD Billion)
  • FIG. 39 Global esoteric lab tests market, 2017 - 2028 (USD Billion)
  • FIG. 40 Global personalized medicine therapeutics market, 2017 - 2028 (USD Billion)
  • FIG. 41 Global pharmaceuticals market, 2017 - 2028 (USD Billion)
  • FIG. 42 Global genomic medicine market, 2017 - 2028 (USD Billion)
  • FIG. 43 Global medical devices market, 2017 - 2028 (USD Billion)
  • FIG. 44 Global personalized medical care market, 2017 - 2028 (USD Billion)
  • FIG. 45 Global telemedicine market, 2017 - 2028 (USD Billion)
  • FIG. 46 Global health information technology market, 2017 - 2028 (USD Billion)
  • FIG. 47 Global personalized nutrition & wellness market, 2017 - 2028 (USD Billion)
  • FIG. 48 Global retail nutrition market, 2017 - 2028 (USD Billion)
  • FIG. 49 Global complementary & alternative medicine market, 2017 - 2028 (USD Billion)
  • FIG. 50 Regional market place: Key takeaway
  • FIG. 51 Personalized medicine regional outlook, 2020 & 2028
  • FIG. 52 North America personalized medicine market, 2017 - 2028 (USD Billion)
  • FIG. 53 U.S. personalized medicine market, 2017 - 2028 (USD Billion)
  • FIG. 54 Canada personalized medicine market, 2017 - 2028 (USD Billion)
  • FIG. 55 Europe personalized medicine market, 2017 - 2028 (USD Billion)
  • FIG. 56 Germany personalized medicine market, 2017 - 2028 (USD Billion)
  • FIG. 57 U.K. personalized medicine market, 2017 - 2028 (USD Billion)
  • FIG. 58 Italy personalized medicine market, 2017 - 2028 (USD Billion)
  • FIG. 59 France personalized medicine market, 2017 - 2028 (USD Billion)
  • FIG. 60 Asia Pacific personalized medicine market, 2017 - 2028 (USD Billion)
  • FIG. 61 Japan personalized medicine market, 2017 - 2028 (USD Billion)
  • FIG. 62 China personalized medicine market, 2017 - 2028 (USD Billion)
  • FIG. 63 India personalized medicine market, 2017 - 2028 (USD Billion)
  • FIG. 64 South Korea personalized medicine market, 2017 - 2028 (USD Billion)
  • FIG. 65 Latin America personalized medicine market, 2017 - 2028 (USD Billion)
  • FIG. 66 Brazil personalized medicine market, 2017 - 2028 (USD Billion)
  • FIG. 67 Mexico personalized medicine market, 2017 - 2028 (USD Billion)
  • FIG. 68 Middle East & Africa personalized medicine market, 2017 - 2028 (USD Billion)
  • FIG. 69 South Africa personalized medicine market, 2017 - 2028 (USD Billion)
  • FIG. 70 Saudi Arabia personalized medicine market, 2017 - 2028 (USD Billion)
  • FIG. 71 Strategy framework
  • FIG. 72 Participant categorization